| Website | ablexis.com |
| @ablexis | |
| Category | BioTech |
| Phone | (415) 978-2177 |
| info@ablexis.com | |
| Employees | |
| Founded | 2009 |
| TOTAL | $12M |
| FUNDING TOTAL | $12M |
| Series A, 6/10 Third Rock Ventures Pfizer Venture Investments | $12M |
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, was founded in December 2009, based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc.
